Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome

被引：52
|
作者：
Allen, RP
Mignot, E
Ripley, B
Nishino, S
Earley, CJ
机构：
[1] Stanford Univ, Ctr Narcolepsy, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Psychiat, Palo Alto, CA 94304 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA
来源：
NEUROLOGY | 2002年 / 59卷 / 04期
关键词：
D O I：
10.1212/WNL.59.4.639
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Hypocretin-1 levels were increased in evening CSF samples from subjects with restless legs syndrome, indicating altered hypocretin transmission in this sleep disorder. Increases in CSF hypocretin-1 levels were most striking in patients with early-onset restless legs syndrome.
引用
收藏
页码：639 / 641
页数：3
相关论文
共 50 条
  • [1] CSF hypocretin-1 levels in restless legs syndrome
    Stiasny-Kolster, K
    Mignot, E
    Ling, L
    Möller, JC
    Cassel, W
    Oertel, WH
    NEUROLOGY, 2003, 61 (10) : 1426 - 1429
  • [2] Circadian variation of hypocretin-1 (orexin A) in restless legs syndrome
    Baier, Paul Christian
    Goeder, Robert
    Hallschmid, Manfred
    SLEEP MEDICINE, 2009, 10 (02) : 271 - 271
  • [3] Circadian variation of hypocretin-1 (orexin A) in restless legs syndrome Reply
    Poceta, J. Steven
    Kripke, Daniel
    SLEEP MEDICINE, 2009, 10 (02) : 272 - 272
  • [4] Increased CSF hypocretin-1 (Orexin-A) in early- versus late-onset restless legs syndrome (RLS): Effects of iron status and amount of activity
    Allen, RP
    Mignot, E
    Ripley, B
    Nishino, S
    Earley, CJ
    NEUROLOGY, 2002, 58 (07) : A514 - A514
  • [5] CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage
    Dohi, K.
    Ripley, B.
    Fujiki, N.
    Nakamachi, T.
    Ohtaki, H.
    Shioda, S.
    Aruga, T.
    Nishino, S.
    REGULATORY PEPTIDES, 2006, 135 (03) : 193 - 193
  • [6] EVALUATION OF COMMERCIAL RIA AND ELISA FOR MEASURING CSF OREXIN-A (HYPOCRETIN-1)
    Ono, T.
    SLEEP, 2017, 40 : A247 - A247
  • [7] CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH)
    Dohi, Kenji
    Ripley, Beth
    Fujiki, Nobuhiro
    Ohtaki, Hirokazu
    Yamamoto, Takefumi
    Goto, Yoko
    Nakamachi, Tomoya
    Shioda, Seiji
    Aruga, Tohru
    Nishino, Seiji
    REGULATORY PEPTIDES, 2008, 145 (1-3) : 60 - 64
  • [8] Decreased CSF hypocretin-1 (Orexin-A) level in narcolepsy without cataplexy
    Oka, Y
    Inoue, Y
    Kanbayashi, T
    Ikeda, A
    Shimizu, T
    Shibasaki, H
    SLEEP, 2003, 26 : A282 - A282
  • [9] CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH)
    Dohi, K
    Ripley, B
    Fujiki, N
    Ohtaki, H
    Shioda, S
    Aruga, T
    Nishino, S
    PEPTIDES, 2005, 26 (11) : 2339 - 2343
  • [10] CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders
    Arii, J
    Kanbayashi, T
    Tanabe, Y
    Sawaishi, Y
    Kimura, S
    Watanabe, A
    Mishima, K
    Hishikawa, Y
    Shimizu, T
    Nishino, S
    NEUROLOGY, 2004, 63 (12) : 2440 - 2442
12345